Therapeutic Drug Monitoring Market by Product (Equipment and Consumables), by Drug Class (Antiarrhythmic Drugs, Antiepileptic Drugs, Antibiotic Drugs,Immunosuppressant Drugs, Psychoactive Drugs, Bronchodilator Drugs, and Others), and by End-User(Commercial/Private Labs, Hospital Labs, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020 - 2029

                                          
Abstract
                    
The report covers forecast and analysis for the therapeutic drug monitoring market on a global and regional level. The study provides historical data from 2015, 2016, 2017along with a forecast from 2018 to 2024based revenue (USD Billion). The study includes drivers and restraints for the therapeutic drug monitoring market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the therapeutic drug monitoring market on a global level.

In order to give the users of this report a comprehensive view of the therapeutic drug monitoring market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a customer and region segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, regional expansion of major participants involved in the market on a global and regional basis. 

The study provides a decisive view of the therapeutic drug monitoring market by segmenting the market based on customer and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018to 2024. 

On the basis of product type, the global therapeutic drug monitoring market is segmented into equipment and consumables. On the basis of drug class, the market is segmented into antiepileptic drugs, antiarrhythmic drugs, immunosuppressant drugs, antibiotic drugs, bronchodilator drugs, psychoactive drug, and others. On the basis of the end-user segment, the market is segmented into commercial/private labs, hospital lab, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. 

Some key players of the global therapeutic drug monitoring market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Siemens Healthcare, Bio-Rad Laboratories Inc., and Danaher Corporation, among others.

This report segments the global therapeutic drug monitoring market as follows:

Global Therapeutic Drug Monitoring Market: ProductType Segment Analysis

	Equipment
	Consumables

Global Therapeutic Drug Monitoring Market: Drug Class Segment Analysis

	Antiepileptic Drugs
	Antiarrhythmic Drugs
	Immunosuppressant Drugs
	Antibiotic Drugs
	Bronchodilator Drugs
	Psychoactive Drugs
	Others

Global Therapeutic Drug Monitoring Market: End-User Segment Analysis

	Commercial/Private Labs
	Hospital Labs
	Others

Global Therapeutic Drug Monitoring Market: Regional Segment Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	The Middle East and Africa